CompuMed revenues up, losses down in Q1

Bone densitometry developer CompuMed reported a slight increase in revenues as well as a reduction in its net loss for its first fiscal quarter of 2004.

The Los Angeles-based company reported revenues of $460,000 for the period (end-December 31, 2003) compared with revenues of $452,000 for the same period the previous year. Net loss for the quarter was $61,000, a reduction of 60% compared with a net loss of $147,000 for the same quarter of fiscal 2003.

The firm said that although revenues in its electrocardiogram product line were down, its OsteoGram sales rose by 314%, with much of this business coming from Asia, where CompuMed has focused its distribution-related efforts over the past year.

By AuntMinnie.com staff writers
February 17, 2004

Related Reading

CompuMed signs for credit line, January 12, 2004

CompuMed sales edge lower, December 30, 2003

Orex to license CompuMed OsteoGram software, November 5, 2003

CompuMed inks deal with NIR, October 28, 2003

CompuMed, Medstrat set partnership, October 21, 2003

Copyright © 2004 AuntMinnie.com

Page 1 of 373
Next Page